Cibus CBUS
NASDAQ CBUS
$1.70 +0.00 (+0.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cibus (CBUS) Cash & Equivalents (2016 - 2026)

Cibus (CBUS) posted Cash & Equivalents of $9.9 million for Q4 2025, down 58.48% sequentially from $23.9 million in Q3 2025, and down 31.25% YoY from $14.4 million in Q4 2024.

Cibus (CBUS) Cash & Equivalents (2016 - 2026) Analysis & Trends

Cibus has reported Cash & Equivalents for 10 years, with the latest figure at $9.9 million in Q4 2025.

  • Quarterly Cash & Equivalents fell 31.25% year-over-year to $9.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.9 million (down 31.25% YoY) and the FY2025 annual result came in at $9.9 million, down 31.25% from the prior year.
  • Cash & Equivalents retreated to $9.9 million in Q4 2025 per CBUS's latest filing, from $23.9 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $50.9 million in Q2 2023 and troughed at $2.1 million in Q1 2023.
  • A 5-year average of $20.5 million and a median of $17.4 million in 2021 frame the typical range for Cash & Equivalents.
  • The sharpest annual moves came in 2023 and 2024: Cash & Equivalents tumbled 88.12% in 2023, then surged 1093.14% in 2024.
  • Over 5 years, Cash & Equivalents stood at $13.8 million in 2021, then tumbled by 75.21% to $3.4 million in 2022, then surged by 854.16% to $32.7 million in 2023, then slumped by 55.86% to $14.4 million in 2024, then tumbled by 31.25% to $9.9 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods registered $9.9 million, $23.9 million, and $36.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 3.58 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 1.72 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.71 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 8.93 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 544.80 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 811.99 Mn
10 Cibus 129.72 Mn 109.29 Mn - 20.43 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 20.43 Mn
Dec 31, 2025 9.92 Mn
Sep 30, 2025 23.90 Mn
Jun 30, 2025 36.50 Mn
Mar 31, 2025 23.59 Mn
Dec 31, 2024 14.43 Mn
Sep 30, 2024 28.81 Mn
Jun 30, 2024 30.00 Mn
Mar 31, 2024 24.51 Mn
Dec 31, 2023 32.70 Mn
Sep 30, 2023 31.88 Mn
Jun 30, 2023 50.90 Mn
Mar 31, 2023 2.05 Mn
Dec 31, 2022 3.43 Mn
Sep 30, 2022 7.03 Mn
Jun 30, 2022 11.32 Mn
Mar 31, 2022 17.29 Mn
Dec 31, 2021 13.82 Mn
Sep 30, 2021 13.92 Mn
Jun 30, 2021 17.49 Mn